UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

International journal of environmental research and public health, 2021-05, Vol.18 (10), p.5227

2021

Volltextzugriff (PDF)

The 3Rs in Experimental Liver Disease

Animals (Basel), 2023-07, Vol.13 (14), p.2357

2023

Volltextzugriff (PDF)

AIM2 deficiency reduces the development of hepatocellular carcinoma in mice

International journal of cancer, 2018-12, Vol.143 (11), p.2997-3007

2018

Volltextzugriff (PDF)

Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response

Liver international, 2024-04, Vol.44 (4), p.996-1010

2024

Volltextzugriff (PDF)

Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

JHEP reports, 2023-08, Vol.5 (8), p.100756-100756, Article 100756

2023

Volltextzugriff (PDF)

Gut microbiota-related complications in cirrhosis

World journal of gastroenterology : WJG, 2014-11, Vol.20 (42), p.15624-15631

2014

Volltextzugriff (PDF)

Bacterial antigen translocation and age as BMI‐independent contributing factors on systemic inflammation in NAFLD patients

Liver international, 2020-09, Vol.40 (9), p.2182-2193

2020

Volltextzugriff (PDF)

Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis

PloS one, 2011-07, Vol.6 (7), p.e23037

2011

Volltextzugriff (PDF)

Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis

Liver international, 2014-07, Vol.34 (6), p.850-858

2014

Volltextzugriff (PDF)

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis

Liver international, 2018-02, Vol.38 (2), p.295-302

2018

Volltextzugriff (PDF)

Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis

Journal of gastroenterology and hepatology, 2015-01, Vol.30 (1), p.147-154

2015

Volltextzugriff (PDF)

Interleukin‐10–mediated heme oxygenase 1–induced underlying mechanism in inflammatory down‐regulation by norfloxacin in cirrhosis

Hepatology (Baltimore, Md.), 2011-03, Vol.53 (3), p.935-944

2011

Volltextzugriff (PDF)

Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short‐Chain Fatty Acids in Experimental Cirrhosis

Hepatology communications, 2018-12, Vol.2 (12), p.1610-1623

2018

Volltextzugriff (PDF)

Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis

Cells (Basel, Switzerland), 2020-05, Vol.9 (5), p.1227

2020

Volltextzugriff (PDF)

Interleukin-10-Mediated Heme Oxygenase 1-Induced Underlying Mechanism in Inflammatory Down-Regulation by Norfloxacin in Cirrhosis

Hepatology (Baltimore, Md.), 2011-03, Vol.53 (3), p.935-944

2011

Volltextzugriff (PDF)

Beta-adrenergic receptor 1 selective antagonism inhibits norepinephrine-mediated TNF-alpha downregulation in experimental liver cirrhosis

PloS one, 2012-08, Vol.7 (8), p.e43371

2012

Volltextzugriff (PDF)

Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765

European journal of nutrition, 2019-06, Vol.58 (4), p.1647-1658

2019

Volltextzugriff (PDF)

Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis

Journal of hepatology, 2016-01, Vol.64 (1), p.135-145

2016

Volltextzugriff (PDF)

Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis

Journal of hepatology, 2015-01, Vol.62 (1), p.64-71

2015

Volltextzugriff (PDF)

Microbiome and bacterial translocation in cirrhosis

Gastroenterología y hepatología, 2016-12, Vol.39 (10), p.687-696

2016

Volltextzugriff (PDF)

Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis

European journal of nutrition, 2016-02, Vol.55 (1), p.197-206

2016

Volltextzugriff (PDF)

Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis

Liver international, 2016-12, Vol.36 (12), p.1811-1820

2016

Volltextzugriff (PDF)

Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis

Journal of hepatology, 2014-10, Vol.61 (4), p.799-808

2014

Volltextzugriff (PDF)

THU-341 - Study of epigenetic control of LSECtin in hepatic antigen presenting cells during experimental cirrhosis

Journal of hepatology, 2023-06, Vol.78, p.S210-S212

2023

Volltextzugriff (PDF)

Study of epigenetic control of LSECtin in hepatic antigen presenting cells during experimental cirrhosis

Journal of hepatology, 2023-06, Vol.78, p.S210-S212

2023

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

The 3Rs in Experimental Liver Disease

AIM2 deficiency reduces the development of hepatocellular carcinoma in mice

Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response

Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

Gut microbiota-related complications in cirrhosis

Bacterial antigen translocation and age as BMI‐independent contributing factors on systemic inflammation in NAFLD patients

Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis

Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis

Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis

Interleukin‐10–mediated heme oxygenase 1–induced underlying mechanism in inflammatory down‐regulation by norfloxacin in cirrhosis

Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short‐Chain Fatty Acids in Experimental Cirrhosis

Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis

Interleukin-10-Mediated Heme Oxygenase 1-Induced Underlying Mechanism in Inflammatory Down-Regulation by Norfloxacin in Cirrhosis

Beta-adrenergic receptor 1 selective antagonism inhibits norepinephrine-mediated TNF-alpha downregulation in experimental liver cirrhosis

Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765

Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis

Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis

Microbiome and bacterial translocation in cirrhosis

Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis

Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis

Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis

THU-341 - Study of epigenetic control of LSECtin in hepatic antigen presenting cells during experimental cirrhosis

Study of epigenetic control of LSECtin in hepatic antigen presenting cells during experimental cirrhosis

Suchergebnisse filtern